DCM
YARW

DAFNA Capital Management’s Yarrow Bioscience YARW Stock Holding History

DAFNA Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,722
Closed -$1.05M – 82
2025
Q2 		$1.05M Hold
12,722
– – 0.29% 56
2025
Q1 		$1.01M Buy
+12,722
New +$1.57M 0.29% 57
2020
Q1 		– Sell
-222
Closed -$3.7M – 85
2019
Q4 		$3.7M Sell
222
-16
-7% -$267K 1.27% 21
2019
Q3 		$3.84M Buy
238
+71
+43% +$1.15M 1.44% 21
2019
Q2 		$3.59M Hold
167
– – 1.35% 24
2019
Q1 		$4.71M Buy
167
+17
+11% +$408K 2.03% 14
2018
Q4 		$2.23M Buy
150
+63
+72% +$1.41M 1.11% 28
2018
Q3 		$3.07M Hold
87
– – 1.26% 28
2018
Q2 		$2.53M Buy
+87
New +$3.38M 1.19% 26

Other funds holding YARW

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

DAFNA Capital Management's YARW Position: Q3 2025 in Review

DAFNA Capital Management sold out of Yarrow Bioscience (YARW) in Q3 2025, closing a stake of 12,722 shares — an estimated $1.05M sold.

DAFNA Capital Management first reported a position in YARW in Q2 2018 and held it in 9 quarters. The position peaked at $4.71M in Q1 2019. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • DAFNA Capital Management reported no remaining Yarrow Bioscience position as of Q3 2025 after selling out during the quarter.
  • DAFNA Capital Management sold 12,722 Yarrow Bioscience shares in Q3 2025, an estimated $1.05M.
  • DAFNA Capital Management first reported a position in Yarrow Bioscience in Q2 2018 and held it in 9 quarters.
  • DAFNA Capital Management's Yarrow Bioscience position peaked at $4.71M in Q1 2019.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2025.

Based on DAFNA Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.